The authors concluded that evidence was not sufficiently robust, or applicable to current clinical practice, to allow the comparative effectiveness of management strategies for adults with asymptomatic carotid stenosis. These conclusions reflect the evidence presented and seem reliable.
Data extraction
Data on number of events per outcome (stated above) were extracted from individual studies to calculate risk ratios and 95% confidence intervals for RCTS and NRCs, and incidence rates and 95% confidence intervals for single cohort studies. When raw data were reported for the cohort studies, data on incidence rates was extracted from published Kaplan-Meier curves. One reviewer extracted the data; a second reviewer checked the extractions for completeness and accuracy.
Methods of synthesis
Risk ratios of RCTs and NRC studies were separately pooled using inverse variance random-effects models. Betweenstudy heterogeneity was assessed using Ι². Where populations of the studies varied considerably, narrative synthesis of their results was presented instead. Pooled incidence rates (percentage per year) of cohort studies were obtained by use of a random-intercept generalised linear model. A meta-regression analysis was conducted to explore the effect of time on the incidence rates of ipsilateral stroke.
Results of the review
Forty-seven studies in 56 publications were included in the review (number of participants 36 to 238,389). Risks of bias for studies were reported in each section of the results (below).
Carotid artery stenting plus medical therapy versus carotid endarterectomy plus medical therapy
Overall there were three RCTs and 10 NRC studies. Four NRC studies (all with a high risk of bias) demonstrated a statistically significantly increased risk for peri-procedural stroke (RR 1.74, 95% CI 1.41 to 2.16; Ι²=75%) and death (RR 1.43, 95% CI 1.20 to 1.71; Ι²=0%) with the carotid artery stenting group, compared with the carotid endarterectomy group.
Carotid endarterectomy plus medical therapy versus medical therapy alone
Overall there were three RCTs and eight NRC studies. Compared with medical therapy alone, three RCTs (all with a low risk of bias) showed that carotid endarterectomy plus medical therapy had statistically significant lower risks for long-term outcomes of ipsilateral stroke (RR 0.72, 95% CI 0.58 to 0.90; Ι²=0%), composite outcome of ipsilateral stroke (RR 0.69, 95% CI 0.55 to 0.87; Ι²=0%) and any stroke, including any death within 30 days (RR 0.68, 95% CI 0.56 to 0.82; Ι²=18%).
Two of these RCTs demonstrated that the risk of any stroke (at peri-procedural or 30 day endpoints) was statistically significantly greater with carotid endarterectomy plus medical therapy, than with medical therapy alone (RR 5.94, 95% CI 2.06 to 17.12; Ι²=0%).
Carotid artery stenting plus medical therapy versus medical therapy alone
Of the two NRC studies, one found statistically significantly decreased risks for long-term outcomes of stroke, death and a composite of these two outcomes with carotid artery stenting plus medical therapy compared with medical therapy alone. There was medium risk of bias for this NRC study.
Rate of ipsilateral stroke with medical therapy alone
Overall there were six medical therapy arms of RCTs and 20 cohort studies. The risk of bias for the 26 studies that investigated medical therapy alone was low (eight studies), medium (11 studies) or high (seven studies). The incidence rate of ipsilateral stroke was 1.68% (95% CI 1.34 to 2.11) per year of follow-up. The results were not substantially changed when studies with high risk of bias were removed from the meta-analysis. Meta-regression analyses demonstrated that the incidence of ipsilateral stroke was statistically significantly lower in studies that completed their recruitment of patients between 2000 and 2010, compared with those that completed it earlier.
No other statistically significant results were reported.
